On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Mar 18, 2025
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "On the Move" is looking at how exercise can help people recover from diabetic foot ulcers. These ulcers can make it difficult for people with diabetes to stay active, and being less mobile can lead to more serious health issues. This study will test a new exercise program that starts with in-person sessions and then moves to home-based workouts, aiming to improve mobility and strength without causing the ulcers to come back.
To participate in this trial, you need to be at least 50 years old, have diabetes, and have had a plantar foot ulcer that healed in the last 3 to 15 months. You should also be able to walk without a walker and be willing to wear the right shoes for exercise. If you join the study, you'll be part of a program designed to help you stay active and healthy, which is important for your overall well-being. Keep in mind that not everyone will be eligible, especially if you have other serious conditions or are expecting foot surgery soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults \>= 50 years
- • Diagnosis of diabetes
- • Plantar foot ulcer which healed within the last 3-15 months
- • Two feet (can have healed minor amputations of fore and midfoot)
- • Willing to wear appropriately fitted footwear for exercise regimen
- • Ambulatory without walker
- • Willing to enroll in the PODIMETRICS SmartMat program
- • Able to give written informed consent
- Exclusion Criteria:
- • Unable to perform the exercise interventions (e.g. due to hearing or visual impairment)
- • Anticipated foot surgery in the next 4 months
- • Participating in another exercise program
- • Severe peripheral arterial disease (Fontaine stage 3 rest pain or 4 ischemic ulcers/gangrene)
- • Current plantar foot ulcer
- • Any other criteria which, in the investigator's opinion, would compromise the ability of a subject to participate safely
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported